APO Research
Talk to an analyst

APO RESEARCH · REPORT

In Vitro Diagnostic Devices

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global In Vitro Diagnostic Devices Market Analysis and Forecast 2026-2032

30 December 2025219 pages

Choose your research edition.

Industry ResearchIn Vitro Diagnostic Devices Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal In Vitro Diagnostic Devices Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal In Vitro Diagnostic Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In Vitro Diagnostic Devices Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal In Vitro Diagnostic Devices Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global In Vitro Diagnostic Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of In Vitro Diagnostic Devices include Abbott, Thermo Fisher Scientific, Roche, Wondfo, Sysmex, Siemens Healthineers, Qiagen, Ortho Clinical Diagnostics and Myriad Genetics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for In Vitro Diagnostic Devices, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of In Vitro Diagnostic Devices, also provides the revenue of main regions and countries. Of the upcoming market potential for In Vitro Diagnostic Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the In Vitro Diagnostic Devices revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global In Vitro Diagnostic Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for In Vitro Diagnostic Devices revenue, projected growth trends, production technology, application and end-user industry.

In Vitro Diagnostic Devices Segment by Company

Abbott

Thermo Fisher Scientific

Roche

Wondfo

Sysmex

Siemens Healthineers

Qiagen

Ortho Clinical Diagnostics

Myriad Genetics

Mindray

LG Chem

Leadman Biochemistry

KHB

Johnson and Johnson

Hologic

Danaher

DAAN Gene

BioSino

Bio-Rad Laboratories

Biomerieux

Becton Dickinson

In Vitro Diagnostic Devices Segment by Type

POCT

Molecular Diagnostics

Chemistry Diagnostics

Immuno Diagnostics

Other

In Vitro Diagnostic Devices Segment by Application

Hospitals

Laboratory

Other

In Vitro Diagnostic Devices Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Diagnostic Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In Vitro Diagnostic Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Diagnostic Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of In Vitro Diagnostic Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of In Vitro Diagnostic Devices company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vitro Diagnostic Devices revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In Vitro Diagnostic Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. POCT Major Player Table 3. Molecular Diagnostics Major Player Table 4. Chemistry Diagnostics Major Player Table 5. Immuno Diagnostics Major Player Table 6. Other Major Player Table 7. Global In Vitro Diagnostic Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals Major Player Table 9. Laboratory Major Player Table 10. Other Major Player Table 11. In Vitro Diagnostic Devices Industry Trends Table 12. In Vitro Diagnostic Devices Industry Drivers Table 13. In Vitro Diagnostic Devices Industry Opportunities and Challenges Table 14. In Vitro Diagnostic Devices Industry Restraints Table 15. Global In Vitro Diagnostic Devices Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global In Vitro Diagnostic Devices Market Size by Region (2021-2026) & (US$ Million) Table 17. Global In Vitro Diagnostic Devices Market Share by Region (2021-2026) Table 18. Global In Vitro Diagnostic Devices Market Size by Region (2027-2032) & (US$ Million) Table 19. Global In Vitro Diagnostic Devices Market Share by Region (2027-2032) Table 20. Global In Vitro Diagnostic Devices Revenue by Players (US$ Million) & (2021-2026) Table 21. Global In Vitro Diagnostic Devices Revenue Market Share by Players (2021-2026) Table 22. Global In Vitro Diagnostic Devices Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global In Vitro Diagnostic Devices Key Players Headquarters & Area Served Table 24. Global In Vitro Diagnostic Devices Players, Product Type & Application Table 25. Global In Vitro Diagnostic Devices Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global In Vitro Diagnostic Devices by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global In Vitro Diagnostic Devices Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global In Vitro Diagnostic Devices Revenue by Type (2021-2026) & (US$ Million) Table 30. Global In Vitro Diagnostic Devices Revenue by Type (2027-2032) & (US$ Million) Table 31. Global In Vitro Diagnostic Devices Revenue Market Share by Type (2021-2026) Table 32. Global In Vitro Diagnostic Devices Revenue Market Share by Type (2027-2032) Table 33. Global In Vitro Diagnostic Devices Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global In Vitro Diagnostic Devices Revenue by Application (2021-2026) & (US$ Million) Table 35. Global In Vitro Diagnostic Devices Revenue by Application (2027-2032) & (US$ Million) Table 36. Global In Vitro Diagnostic Devices Revenue Market Share by Application (2021-2026) Table 37. Global In Vitro Diagnostic Devices Revenue Market Share by Application (2027-2032) Table 38. Abbott Company Information Table 39. Abbott Business Overview Table 40. Abbott In Vitro Diagnostic Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Abbott In Vitro Diagnostic Devices Product Portfolio Table 42. Abbott Recent Development Table 43. Thermo Fisher Scientific Company Information Table 44. Thermo Fisher Scientific Business Overview Table 45. Thermo Fisher Scientific In Vitro Diagnostic Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Thermo Fisher Scientific In Vitro Diagnostic Devices Product Portfolio Table 47. Thermo Fisher Scientific Recent Development Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche In Vitro Diagnostic Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Roche In Vitro Diagnostic Devices Product Portfolio Table 52. Roche Recent Development Table 53. Wondfo Company Information Table 54. Wondfo Business Overview Table 55. Wondfo In Vitro Diagnostic Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Wondfo In Vitro Diagnostic Devices Product Portfolio Table 57. Wondfo Recent Development Table 58. Sysmex Company Information Table 59. Sysmex Business Overview Table 60. Sysmex In Vitro Diagnostic Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Sysmex In Vitro Diagnostic Devices Product Portfolio Table 62. Sysmex Recent Development Table 63. Siemens Healthineers Company Information Table 64. Siemens Healthineers Business Overview Table 65. Siemens Healthineers In Vitro Diagnostic Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Siemens Healthineers In Vitro Diagnostic Devices Product Portfolio Table 67. Siemens Healthineers Recent Development Table 68. Qiagen Company Information Table 69. Qiagen Business Overview Table 70. Qiagen In Vitro Diagnostic Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Qiagen In Vitro Diagnostic Devices Product Portfolio Table 72. Qiagen Recent Development Table 73. Ortho Clinical Diagnostics Company Information Table 74. Ortho Clinical Diagnostics Business Overview Table 75. Ortho Clinical Diagnostics In Vitro Diagnostic Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Ortho Clinical Diagnostics In Vitro Diagnostic Devices Product Portfolio Table 77. Ortho Clinical Diagnostics Recent Development Table 78. Myriad Genetics Company Information Table 79. Myriad Genetics Business Overview Table 80. Myriad Genetics In Vitro Diagnostic Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Myriad Genetics In Vitro Diagnostic Devices Product Portfolio Table 82. Myriad Genetics Recent Development Table 83. Mindray Company Information Table 84. Mindray Business Overview Table 85. Mindray In Vitro Diagnostic Devices Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Mindray In Vitro Diagnostic Devices Product Portfolio Table 87. Mindray Recent Development Table 88. LG Chem Company Information Table 89. LG Chem Business Overview Table 90. LG Chem In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. LG Chem In Vitro Diagnostic Devices Product Portfolio Table 92. LG Chem Recent Development Table 93. Leadman Biochemistry Company Information Table 94. Leadman Biochemistry Business Overview Table 95. Leadman Biochemistry In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Leadman Biochemistry In Vitro Diagnostic Devices Product Portfolio Table 97. Leadman Biochemistry Recent Development Table 98. KHB Company Information Table 99. KHB Business Overview Table 100. KHB In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. KHB In Vitro Diagnostic Devices Product Portfolio Table 102. KHB Recent Development Table 103. Johnson and Johnson Company Information Table 104. Johnson and Johnson Business Overview Table 105. Johnson and Johnson In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Johnson and Johnson In Vitro Diagnostic Devices Product Portfolio Table 107. Johnson and Johnson Recent Development Table 108. Hologic Company Information Table 109. Hologic Business Overview Table 110. Hologic In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hologic In Vitro Diagnostic Devices Product Portfolio Table 112. Hologic Recent Development Table 113. Danaher Company Information Table 114. Danaher Business Overview Table 115. Danaher In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Danaher In Vitro Diagnostic Devices Product Portfolio Table 117. Danaher Recent Development Table 118. DAAN Gene Company Information Table 119. DAAN Gene Business Overview Table 120. DAAN Gene In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. DAAN Gene In Vitro Diagnostic Devices Product Portfolio Table 122. DAAN Gene Recent Development Table 123. BioSino Company Information Table 124. BioSino Business Overview Table 125. BioSino In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. BioSino In Vitro Diagnostic Devices Product Portfolio Table 127. BioSino Recent Development Table 128. Bio-Rad Laboratories Company Information Table 129. Bio-Rad Laboratories Business Overview Table 130. Bio-Rad Laboratories In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Bio-Rad Laboratories In Vitro Diagnostic Devices Product Portfolio Table 132. Bio-Rad Laboratories Recent Development Table 133. Biomerieux Company Information Table 134. Biomerieux Business Overview Table 135. Biomerieux In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Biomerieux In Vitro Diagnostic Devices Product Portfolio Table 137. Biomerieux Recent Development Table 138. Becton Dickinson Company Information Table 139. Becton Dickinson Business Overview Table 140. Becton Dickinson In Vitro Diagnostic Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Becton Dickinson In Vitro Diagnostic Devices Product Portfolio Table 142. Becton Dickinson Recent Development Table 143. North America In Vitro Diagnostic Devices Revenue by Type (2021-2026) & (US$ Million) Table 144. North America In Vitro Diagnostic Devices Revenue by Type (2027-2032) & (US$ Million) Table 145. North America In Vitro Diagnostic Devices Revenue by Application (2021-2026) & (US$ Million) Table 146. North America In Vitro Diagnostic Devices Revenue by Application (2027-2032) & (US$ Million) Table 147. North America In Vitro Diagnostic Devices Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America In Vitro Diagnostic Devices Revenue by Country (2021-2026) & (US$ Million) Table 149. North America In Vitro Diagnostic Devices Revenue by Country (US$ Million) & (2027-2032) Table 150. Europe In Vitro Diagnostic Devices Revenue by Type (2021-2026) & (US$ Million) Table 151. Europe In Vitro Diagnostic Devices Revenue by Type (2027-2032) & (US$ Million) Table 152. Europe In Vitro Diagnostic Devices Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe In Vitro Diagnostic Devices Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe In Vitro Diagnostic Devices Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Europe In Vitro Diagnostic Devices Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe In Vitro Diagnostic Devices Revenue by Country (US$ Million) & (2027-2032) Table 157. China In Vitro Diagnostic Devices Revenue by Type (2021-2026) & (US$ Million) Table 158. China In Vitro Diagnostic Devices Revenue by Type (2027-2032) & (US$ Million) Table 159. China In Vitro Diagnostic Devices Revenue by Application (2021-2026) & (US$ Million) Table 160. China In Vitro Diagnostic Devices Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia In Vitro Diagnostic Devices Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia In Vitro Diagnostic Devices Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia In Vitro Diagnostic Devices Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia In Vitro Diagnostic Devices Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia In Vitro Diagnostic Devices Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia In Vitro Diagnostic Devices Revenue by Region (US$ Million) & (2021-2026) Table 167. Asia In Vitro Diagnostic Devices Revenue by Region (US$ Million) & (2027-2032) Table 168. SAMEA In Vitro Diagnostic Devices Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA In Vitro Diagnostic Devices Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA In Vitro Diagnostic Devices Revenue by Application (2021-2026) & (US$ Million) Table 171. SAMEA In Vitro Diagnostic Devices Revenue by Application (2027-2032) & (US$ Million) Table 172. SAMEA In Vitro Diagnostic Devices Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. SAMEA In Vitro Diagnostic Devices Revenue by Country (2021-2026) & (US$ Million) Table 174. SAMEA In Vitro Diagnostic Devices Revenue by Country (US$ Million) & (2027-2032) Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. In Vitro Diagnostic Devices Image Figure 2. Global In Vitro Diagnostic Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global In Vitro Diagnostic Devices Market Size Share 2021 VS 2025 VS 2032 Figure 4. POCT Image Figure 5. Molecular Diagnostics Image Figure 6. Chemistry Diagnostics Image Figure 7. Immuno Diagnostics Image Figure 8. Other Image Figure 9. Global In Vitro Diagnostic Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global In Vitro Diagnostic Devices Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Laboratory Image Figure 13. Other Image Figure 14. Global In Vitro Diagnostic Devices Market Size (US$ Million) & (2021-2032) Figure 15. Global In Vitro Diagnostic Devices Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global In Vitro Diagnostic Devices Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global In Vitro Diagnostic Devices Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global In Vitro Diagnostic Devices Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global In Vitro Diagnostic Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global In Vitro Diagnostic Devices Revenue Market Share by Type (2021-2032) Figure 22. Global In Vitro Diagnostic Devices Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global In Vitro Diagnostic Devices Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global In Vitro Diagnostic Devices Revenue Market Share by Application (2021-2032) Figure 25. North America In Vitro Diagnostic Devices Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America In Vitro Diagnostic Devices Revenue Share by Type (2021-2032) Figure 27. North America In Vitro Diagnostic Devices Revenue Share by Application (2021-2032) Figure 28. North America In Vitro Diagnostic Devices Revenue Share by Country (2021-2032) Figure 29. United States In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe In Vitro Diagnostic Devices Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe In Vitro Diagnostic Devices Revenue Share by Type (2021-2032) Figure 34. Europe In Vitro Diagnostic Devices Revenue Share by Application (2021-2032) Figure 35. Europe In Vitro Diagnostic Devices Revenue Share by Country (2021-2032) Figure 36. Germany In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China In Vitro Diagnostic Devices Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China In Vitro Diagnostic Devices Revenue Share by Type (2021-2032) Figure 46. China In Vitro Diagnostic Devices Revenue Share by Application (2021-2032) Figure 47. Asia In Vitro Diagnostic Devices Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia In Vitro Diagnostic Devices Revenue Share by Type (2021-2032) Figure 49. Asia In Vitro Diagnostic Devices Revenue Share by Application (2021-2032) Figure 50. Asia In Vitro Diagnostic Devices Revenue Share by Region (2021-2032) Figure 51. Japan In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA In Vitro Diagnostic Devices Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA In Vitro Diagnostic Devices Revenue Share by Type (2021-2032) Figure 59. SAMEA In Vitro Diagnostic Devices Revenue Share by Application (2021-2032) Figure 60. SAMEA In Vitro Diagnostic Devices Revenue Share by Country (2021-2032) Figure 61. Brazil In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt In Vitro Diagnostic Devices Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • POCT
  • Molecular Diagnostics
  • Chemistry Diagnostics
  • Immuno Diagnostics
  • Other
Applications
  • Hospitals
  • Laboratory
  • Other
Companies covered
  • Abbott
  • Thermo Fisher Scientific
  • Roche
  • Wondfo
  • Sysmex
  • Siemens Healthineers
  • Qiagen
  • Ortho Clinical Diagnostics
  • Myriad Genetics
  • Mindray
  • LG Chem
  • Leadman Biochemistry
  • KHB
  • Johnson and Johnson
  • Hologic
  • Danaher
  • DAAN Gene
  • BioSino
  • Bio-Rad Laboratories
  • Biomerieux
  • Becton Dickinson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 In Vitro Diagnostic Devices Market by Type
  3. 1.2.1 Global In Vitro Diagnostic Devices Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 POCT
  5. 1.2.3 Molecular Diagnostics
  6. 1.2.4 Chemistry Diagnostics
  7. 1.2.5 Immuno Diagnostics
  8. 1.2.6 Other
  9. 1.3 In Vitro Diagnostic Devices Market by Application
  10. 1.3.1 Global In Vitro Diagnostic Devices Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Laboratory
  13. 1.3.4 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 In Vitro Diagnostic Devices Market Dynamics
  1. 2.1 In Vitro Diagnostic Devices Industry Trends
  2. 2.2 In Vitro Diagnostic Devices Industry Drivers
  3. 2.3 In Vitro Diagnostic Devices Industry Opportunities and Challenges
  4. 2.4 In Vitro Diagnostic Devices Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global In Vitro Diagnostic Devices Market Perspective (2021-2032)
  2. 3.2 Global In Vitro Diagnostic Devices Growth Trends by Region
  3. 3.2.1 Global In Vitro Diagnostic Devices Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global In Vitro Diagnostic Devices Market Size by Region (2021-2026)
  5. 3.2.3 Global In Vitro Diagnostic Devices Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global In Vitro Diagnostic Devices Revenue by Players
  2. 4.1.1 Global In Vitro Diagnostic Devices Revenue by Players (2021-2026)
  3. 4.1.2 Global In Vitro Diagnostic Devices Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global In Vitro Diagnostic Devices Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global In Vitro Diagnostic Devices Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global In Vitro Diagnostic Devices Key Players Headquarters & Area Served
  7. 4.4 Global In Vitro Diagnostic Devices Players, Product Type & Application
  8. 4.5 Global In Vitro Diagnostic Devices Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global In Vitro Diagnostic Devices Market CR5 and HHI
  11. 4.6.3 2025 In Vitro Diagnostic Devices Tier 1, Tier 2, and Tier 3
5 In Vitro Diagnostic Devices Market Size by Type
  1. 5.1 Global In Vitro Diagnostic Devices Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global In Vitro Diagnostic Devices Revenue by Type (2021-2032)
  3. 5.3 Global In Vitro Diagnostic Devices Revenue Market Share by Type (2021-2032)
6 In Vitro Diagnostic Devices Market Size by Application
  1. 6.1 Global In Vitro Diagnostic Devices Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global In Vitro Diagnostic Devices Revenue by Application (2021-2032)
  3. 6.3 Global In Vitro Diagnostic Devices Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott In Vitro Diagnostic Devices Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Thermo Fisher Scientific
  8. 7.2.1 Thermo Fisher Scientific Company Information
  9. 7.2.2 Thermo Fisher Scientific Business Overview
  10. 7.2.3 Thermo Fisher Scientific In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Scientific In Vitro Diagnostic Devices Product Portfolio
  12. 7.2.5 Thermo Fisher Scientific Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche In Vitro Diagnostic Devices Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 Wondfo
  20. 7.4.1 Wondfo Company Information
  21. 7.4.2 Wondfo Business Overview
  22. 7.4.3 Wondfo In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Wondfo In Vitro Diagnostic Devices Product Portfolio
  24. 7.4.5 Wondfo Recent Developments
  25. 7.5 Sysmex
  26. 7.5.1 Sysmex Company Information
  27. 7.5.2 Sysmex Business Overview
  28. 7.5.3 Sysmex In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Sysmex In Vitro Diagnostic Devices Product Portfolio
  30. 7.5.5 Sysmex Recent Developments
  31. 7.6 Siemens Healthineers
  32. 7.6.1 Siemens Healthineers Company Information
  33. 7.6.2 Siemens Healthineers Business Overview
  34. 7.6.3 Siemens Healthineers In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Siemens Healthineers In Vitro Diagnostic Devices Product Portfolio
  36. 7.6.5 Siemens Healthineers Recent Developments
  37. 7.7 Qiagen
  38. 7.7.1 Qiagen Company Information
  39. 7.7.2 Qiagen Business Overview
  40. 7.7.3 Qiagen In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Qiagen In Vitro Diagnostic Devices Product Portfolio
  42. 7.7.5 Qiagen Recent Developments
  43. 7.8 Ortho Clinical Diagnostics
  44. 7.8.1 Ortho Clinical Diagnostics Company Information
  45. 7.8.2 Ortho Clinical Diagnostics Business Overview
  46. 7.8.3 Ortho Clinical Diagnostics In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Ortho Clinical Diagnostics In Vitro Diagnostic Devices Product Portfolio
  48. 7.8.5 Ortho Clinical Diagnostics Recent Developments
  49. 7.9 Myriad Genetics
  50. 7.9.1 Myriad Genetics Company Information
  51. 7.9.2 Myriad Genetics Business Overview
  52. 7.9.3 Myriad Genetics In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Myriad Genetics In Vitro Diagnostic Devices Product Portfolio
  54. 7.9.5 Myriad Genetics Recent Developments
  55. 7.10 Mindray
  56. 7.10.1 Mindray Company Information
  57. 7.10.2 Mindray Business Overview
  58. 7.10.3 Mindray In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Mindray In Vitro Diagnostic Devices Product Portfolio
  60. 7.10.5 Mindray Recent Developments
  61. 7.11 LG Chem
  62. 7.11.1 LG Chem Company Information
  63. 7.11.2 LG Chem Business Overview
  64. 7.11.3 LG Chem In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  65. 7.11.4 LG Chem In Vitro Diagnostic Devices Product Portfolio
  66. 7.11.5 LG Chem Recent Developments
  67. 7.12 Leadman Biochemistry
  68. 7.12.1 Leadman Biochemistry Company Information
  69. 7.12.2 Leadman Biochemistry Business Overview
  70. 7.12.3 Leadman Biochemistry In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Leadman Biochemistry In Vitro Diagnostic Devices Product Portfolio
  72. 7.12.5 Leadman Biochemistry Recent Developments
  73. 7.13 KHB
  74. 7.13.1 KHB Company Information
  75. 7.13.2 KHB Business Overview
  76. 7.13.3 KHB In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  77. 7.13.4 KHB In Vitro Diagnostic Devices Product Portfolio
  78. 7.13.5 KHB Recent Developments
  79. 7.14 Johnson and Johnson
  80. 7.14.1 Johnson and Johnson Company Information
  81. 7.14.2 Johnson and Johnson Business Overview
  82. 7.14.3 Johnson and Johnson In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Johnson and Johnson In Vitro Diagnostic Devices Product Portfolio
  84. 7.14.5 Johnson and Johnson Recent Developments
  85. 7.15 Hologic
  86. 7.15.1 Hologic Company Information
  87. 7.15.2 Hologic Business Overview
  88. 7.15.3 Hologic In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Hologic In Vitro Diagnostic Devices Product Portfolio
  90. 7.15.5 Hologic Recent Developments
  91. 7.16 Danaher
  92. 7.16.1 Danaher Company Information
  93. 7.16.2 Danaher Business Overview
  94. 7.16.3 Danaher In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Danaher In Vitro Diagnostic Devices Product Portfolio
  96. 7.16.5 Danaher Recent Developments
  97. 7.17 DAAN Gene
  98. 7.17.1 DAAN Gene Company Information
  99. 7.17.2 DAAN Gene Business Overview
  100. 7.17.3 DAAN Gene In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  101. 7.17.4 DAAN Gene In Vitro Diagnostic Devices Product Portfolio
  102. 7.17.5 DAAN Gene Recent Developments
  103. 7.18 BioSino
  104. 7.18.1 BioSino Company Information
  105. 7.18.2 BioSino Business Overview
  106. 7.18.3 BioSino In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  107. 7.18.4 BioSino In Vitro Diagnostic Devices Product Portfolio
  108. 7.18.5 BioSino Recent Developments
  109. 7.19 Bio-Rad Laboratories
  110. 7.19.1 Bio-Rad Laboratories Company Information
  111. 7.19.2 Bio-Rad Laboratories Business Overview
  112. 7.19.3 Bio-Rad Laboratories In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Bio-Rad Laboratories In Vitro Diagnostic Devices Product Portfolio
  114. 7.19.5 Bio-Rad Laboratories Recent Developments
  115. 7.20 Biomerieux
  116. 7.20.1 Biomerieux Company Information
  117. 7.20.2 Biomerieux Business Overview
  118. 7.20.3 Biomerieux In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Biomerieux In Vitro Diagnostic Devices Product Portfolio
  120. 7.20.5 Biomerieux Recent Developments
  121. 7.21 Becton Dickinson
  122. 7.21.1 Becton Dickinson Company Information
  123. 7.21.2 Becton Dickinson Business Overview
  124. 7.21.3 Becton Dickinson In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Becton Dickinson In Vitro Diagnostic Devices Product Portfolio
  126. 7.21.5 Becton Dickinson Recent Developments
8 North America
  1. 8.1 North America In Vitro Diagnostic Devices Revenue (2021-2032)
  2. 8.2 North America In Vitro Diagnostic Devices Revenue by Type (2021-2032)
  3. 8.2.1 North America In Vitro Diagnostic Devices Revenue by Type (2021-2026)
  4. 8.2.2 North America In Vitro Diagnostic Devices Revenue by Type (2027-2032)
  5. 8.3 North America In Vitro Diagnostic Devices Revenue Share by Type (2021-2032)
  6. 8.4 North America In Vitro Diagnostic Devices Revenue by Application (2021-2032)
  7. 8.4.1 North America In Vitro Diagnostic Devices Revenue by Application (2021-2026)
  8. 8.4.2 North America In Vitro Diagnostic Devices Revenue by Application (2027-2032)
  9. 8.5 North America In Vitro Diagnostic Devices Revenue Share by Application (2021-2032)
  10. 8.6 North America In Vitro Diagnostic Devices Revenue by Country
  11. 8.6.1 North America In Vitro Diagnostic Devices Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America In Vitro Diagnostic Devices Revenue by Country (2021-2026)
  13. 8.6.3 North America In Vitro Diagnostic Devices Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe In Vitro Diagnostic Devices Revenue (2021-2032)
  2. 9.2 Europe In Vitro Diagnostic Devices Revenue by Type (2021-2032)
  3. 9.2.1 Europe In Vitro Diagnostic Devices Revenue by Type (2021-2026)
  4. 9.2.2 Europe In Vitro Diagnostic Devices Revenue by Type (2027-2032)
  5. 9.3 Europe In Vitro Diagnostic Devices Revenue Share by Type (2021-2032)
  6. 9.4 Europe In Vitro Diagnostic Devices Revenue by Application (2021-2032)
  7. 9.4.1 Europe In Vitro Diagnostic Devices Revenue by Application (2021-2026)
  8. 9.4.2 Europe In Vitro Diagnostic Devices Revenue by Application (2027-2032)
  9. 9.5 Europe In Vitro Diagnostic Devices Revenue Share by Application (2021-2032)
  10. 9.6 Europe In Vitro Diagnostic Devices Revenue by Country
  11. 9.6.1 Europe In Vitro Diagnostic Devices Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe In Vitro Diagnostic Devices Revenue by Country (2021-2026)
  13. 9.6.3 Europe In Vitro Diagnostic Devices Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China In Vitro Diagnostic Devices Revenue (2021-2032)
  2. 10.2 China In Vitro Diagnostic Devices Revenue by Type (2021-2032)
  3. 10.2.1 China In Vitro Diagnostic Devices Revenue by Type (2021-2026)
  4. 10.2.2 China In Vitro Diagnostic Devices Revenue by Type (2027-2032)
  5. 10.3 China In Vitro Diagnostic Devices Revenue Share by Type (2021-2032)
  6. 10.4 China In Vitro Diagnostic Devices Revenue by Application (2021-2032)
  7. 10.4.1 China In Vitro Diagnostic Devices Revenue by Application (2021-2026)
  8. 10.4.2 China In Vitro Diagnostic Devices Revenue by Application (2027-2032)
  9. 10.5 China In Vitro Diagnostic Devices Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia In Vitro Diagnostic Devices Revenue (2021-2032)
  2. 11.2 Asia In Vitro Diagnostic Devices Revenue by Type (2021-2032)
  3. 11.2.1 Asia In Vitro Diagnostic Devices Revenue by Type (2021-2026)
  4. 11.2.2 Asia In Vitro Diagnostic Devices Revenue by Type (2027-2032)
  5. 11.3 Asia In Vitro Diagnostic Devices Revenue Share by Type (2021-2032)
  6. 11.4 Asia In Vitro Diagnostic Devices Revenue by Application (2021-2032)
  7. 11.4.1 Asia In Vitro Diagnostic Devices Revenue by Application (2021-2026)
  8. 11.4.2 Asia In Vitro Diagnostic Devices Revenue by Application (2027-2032)
  9. 11.5 Asia In Vitro Diagnostic Devices Revenue Share by Application (2021-2032)
  10. 11.6 Asia In Vitro Diagnostic Devices Revenue by Country
  11. 11.6.1 Asia In Vitro Diagnostic Devices Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia In Vitro Diagnostic Devices Revenue by Country (2021-2026)
  13. 11.6.3 Asia In Vitro Diagnostic Devices Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA In Vitro Diagnostic Devices Revenue (2021-2032)
  2. 12.2 SAMEA In Vitro Diagnostic Devices Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA In Vitro Diagnostic Devices Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA In Vitro Diagnostic Devices Revenue by Type (2027-2032)
  5. 12.3 SAMEA In Vitro Diagnostic Devices Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA In Vitro Diagnostic Devices Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA In Vitro Diagnostic Devices Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA In Vitro Diagnostic Devices Revenue by Application (2027-2032)
  9. 12.5 SAMEA In Vitro Diagnostic Devices Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA In Vitro Diagnostic Devices Revenue by Country
  11. 12.6.1 SAMEA In Vitro Diagnostic Devices Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA In Vitro Diagnostic Devices Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA In Vitro Diagnostic Devices Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst